Targeted next-generation sequencing-based detection of microsatellite instability in colorectal carcinomas

In the present study, we developed a computational method and panel markers to assess microsatellite instability (MSI) using a targeted next-generation sequencing (NGS) platform and compared the performance of our computational method, mSILICO, with that of mSINGS to detect MSI in CRCs. We evaluated...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 16; no. 2; p. e0246356
Main Authors Lee, Yunbeom, Lee, Ji Ae, Park, Hye Eun, Han, Hyojun, Kim, Yuhnam, Bae, Jeong Mo, Kim, Jung Ho, Cho, Nam-Yun, Kim, Hwang-Phill, Kim, Tae-You, Kang, Gyeong Hoon
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.02.2021
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In the present study, we developed a computational method and panel markers to assess microsatellite instability (MSI) using a targeted next-generation sequencing (NGS) platform and compared the performance of our computational method, mSILICO, with that of mSINGS to detect MSI in CRCs. We evaluated 13 CRC cell lines, 84 fresh and 119 formalin-fixed CRC tissues (including 61 MSI-high CRCs and 155 microsatellite-stable CRCs) and tested the classification performance of the two methods on 23, 230, and 3,154 microsatellite markers. For the fresh tissue and cell line samples, mSILICO showed a sensitivity of 100% and a specificity of 100%, regardless of the number of panel markers, whereas for the formalin-fixed tissue samples, mSILICO exhibited a sensitivity of up to 100% and a specificity of up to 100% with three differently sized panels ranging from 23 to 3154. These results were similar to those of mSINGS. With the application of mSILICO, the small panel of 23 markers had a sensitivity of ≥95% and a specificity of 100% in cell lines/fresh tissues and formalin-fixed tissues of CRC. In conclusion, we developed a new computational method and microsatellite marker panels for the determination of MSI that does not require paired normal tissues. A small panel could be integrated into the targeted NGS panel for the concurrent analysis of single nucleotide variations and MSI.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors have read the journal’s policy and have the following competing interests: YL, HH, and YK are employees of Celemics, Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The authors have submitted a patent on analysis method and compositions of genetic markers for detecting microsatellite-instability in cancer via next generation sequencing. There are no other patents, products in development or marketed products associated with this research to declare.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0246356